Abstract Details

Title Establishment of Optimal Bioanalytical Parameters for Measuring Neurofilament Light Chain (Nf-L) in Multiple Sclerosis (MS) Subjects from Clinical Trial Cohorts.

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 413

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Akash Datwani, PhD (Genentech/ Roche) PRESENTER	No disclosure on file
Christopher Harp	Christopher Harp has received personal compensation for serving as an employee of Genentech. Christopher Harp has received stock or an ownership interest from Genentech, Inc..
Bruno C. Musch, MD	No disclosure on file
Damian Fiore	No disclosure on file
Ann Herman	Ann Herman has received personal compensation for serving as an employee of Genentech, Inc. Ann Herman has received stock or an ownership interest from F. Hoffman-La Roche Ltd.
Robert Hendricks	No disclosure on file